How commercially ready is your product?
A great healthcare product doesn't automatically become a successful commercial product. The Commercialisation Probability Index (CPI) assesses the factors that influence whether a healthcare product is positioned to achieve commercial adoption.
ASSESSMENT
What is the CPI?
A structured diagnostic developed by Hands Associates. It looks beyond whether a product is clinically effective or technically ready, and scores six areas that determine whether it will actually commercialise.
Adoption Friction
Difficulty of real-world customer/clinician adoption.
Investor Defensibility
Commercial defensibility of the opportunity.
Evidence Maturity
Strength of evidence supporting adoption and commercial decisions.
Reimbursement Alignment
Clarity of reimbursement, funding and procurement routes.
Go-to-Market Readiness
Readiness to reach, convert and support customers.
Operational SOM Confidence
Credibility of accessing and converting the realistically obtainable market.
Your score is ready
Enter your details to see your indicative CPI score.
We'll send your full breakdown of answers and scores to this email address.
YOUR INDICATIVE CPI SCORE: 0/100
Your product shows promising commercial foundations but faces specific hurdles in adoption or evidence that require mitigation.
Assessment Summary
EXPLORE THE CPI FURTHER
The Indicative CPI identifies where commercialisation risk may exist. To discuss your results and how to mitigate these risks, book a review session.
BOOK A CPI REVIEW ON CALENDLY